I agree. This is significant. I sense an announcement is coming.
Global partner for ARDS and NIH sponsored Phase 3 trial for Covid ARDS? Maybe a global trial to try to recruit patients as fast as possible….
And/or announcement of the Phase 3 CLBP trial?
If NIH are funding a new Covid ARDS trial for Reme, I give the chances of aGVHD approval at 95%, as FDA wouldn’t want to waste NIH resources on furthering this along... Both FDA and NIH have the same purse strings.
MSB Trading 2022, The TurnAround, page-509
-
- There are more pages in this discussion • 540 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
-0.010(0.76%) |
Mkt cap ! $1.495B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.33 | $1.28 | $1.819M | 1.396M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 29972 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 2008 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |